BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen RH, Yang LJ, Hamdoun S, Chung SK, Lam CW, Zhang KX, Guo X, Xia C, Law BYK, Wong VKW. 1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection. Front Pharmacol 2021;12:634176. [PMID: 33897423 DOI: 10.3389/fphar.2021.634176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kong L, Meng J, Tian W, Liu J, Hu X, Jiang ZH, Zhang W, Li Y, Bai LP. I2-Catalyzed Carbonylation of α-Methylene Ketones to Synthesize 1,2-Diaryl Diketones and Antiviral Quinoxalines in One Pot. ACS Omega 2022;7:1380-94. [PMID: 35036799 DOI: 10.1021/acsomega.1c06017] [Reference Citation Analysis]
2 Jin Y, Lee J, Jeon S, Kim S, Min JS, Kwon S. Natural Polyphenols, 1,2,3,4,6-O-Pentagalloyglucose and Proanthocyanidins, as Broad-Spectrum Anticoronaviral Inhibitors Targeting Mpro and RdRp of SARS-CoV-2. Biomedicines 2022;10:1170. [DOI: 10.3390/biomedicines10051170] [Reference Citation Analysis]
3 Mahmoud MF, Nabil M, Hasan RA, El-shazly AM, El-ansari MA, Sobeh M. Pentagalloyl Glucose, a Major Compound in Mango Seed Kernel, Exhibits Distinct Gastroprotective Effects in Indomethacin-Induced Gastropathy in Rats via Modulating the NO/eNOS/iNOS Signaling Pathway. Front Pharmacol 2022;13:800986. [DOI: 10.3389/fphar.2022.800986] [Reference Citation Analysis]
4 Coghi P, Yang LJ, Ng JPL, Haynes RK, Memo M, Gianoncelli A, Wong VKW, Ribaudo G. A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2). Pharmaceuticals (Basel) 2021;14:954. [PMID: 34681178 DOI: 10.3390/ph14100954] [Reference Citation Analysis]
5 Vidoni C, Fuzimoto A, Ferraresi A, Isidoro C. Targeting autophagy with natural products to prevent SARS-CoV-2 infection. J Tradit Complement Med 2021. [PMID: 34664025 DOI: 10.1016/j.jtcme.2021.10.003] [Reference Citation Analysis]
6 Ribaudo G, Coghi P, Yang LJ, Ng JPL, Mastinu A, Memo M, Wong VKW, Gianoncelli A. Computational and experimental insights on the interaction of artemisinin, dihydroartemisinin and chloroquine with SARS-CoV-2 spike protein receptor-binding domain (RBD). Nat Prod Res 2021;:1-6. [PMID: 33977847 DOI: 10.1080/14786419.2021.1925894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yang LJ, Chen RH, Hamdoun S, Coghi P, Ng JPL, Zhang DW, Guo X, Xia C, Law BYK, Wong VKW. Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding. Phytomedicine 2021;87:153591. [PMID: 34029937 DOI: 10.1016/j.phymed.2021.153591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 David AB, Diamant E, Dor E, Barnea A, Natan N, Levin L, Chapman S, Mimran LC, Epstein E, Zichel R, Torgeman A. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries. Molecules 2021;26:3213. [PMID: 34072087 DOI: 10.3390/molecules26113213] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Tan H, Ma C, Wang J. Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor. Med Chem Res. [DOI: 10.1007/s00044-022-02903-0] [Reference Citation Analysis]
10 Wang JB, Andrade-Cetto A, Echeverria J, Wardle J, Yen HR, Heinrich M. Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic. Front Pharmacol 2021;12:798674. [PMID: 34925048 DOI: 10.3389/fphar.2021.798674] [Reference Citation Analysis]
11 Guo Y, Meng JR, Liu JZ, Xu T, Zheng ZY, Jiang ZH, Bai LP. Synthesis and Biological Evaluation of Honokiol Derivatives Bearing 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)oxazol-2(3H)-ones as Potential Viral Entry Inhibitors against SARS-CoV-2. Pharmaceuticals (Basel) 2021;14:885. [PMID: 34577585 DOI: 10.3390/ph14090885] [Reference Citation Analysis]